Logo image of AMS

AMERICAN SHARED HOSPITAL SER (AMS) Stock Fundamental Analysis

NYSEARCA:AMS - NYSE Arca - US0295951059 - Common Stock - Currency: USD

2.49  0 (0%)

Fundamental Rating

3

Taking everything into account, AMS scores 3 out of 10 in our fundamental rating. AMS was compared to 103 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of AMS while its profitability can be described as average. AMS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year AMS has reported negative net income.
In the past year AMS had a positive cash flow from operations.
Of the past 5 years AMS 4 years were profitable.
In the past 5 years AMS always reported a positive cash flow from operatings.
AMS Yearly Net Income VS EBIT VS OCF VS FCFAMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

AMS has a Return On Assets (2.28%) which is comparable to the rest of the industry.
AMS has a better Return On Equity (5.85%) than 64.08% of its industry peers.
The Return On Invested Capital of AMS (0.97%) is comparable to the rest of the industry.
AMS had an Average Return On Invested Capital over the past 3 years of 4.67%. This is below the industry average of 9.55%.
Industry RankSector Rank
ROA 2.28%
ROE 5.85%
ROIC 0.97%
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)4.67%
ROIC(5y)N/A
AMS Yearly ROA, ROE, ROICAMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 4.93%, AMS is in the better half of the industry, outperforming 76.70% of the companies in the same industry.
In the last couple of years the Profit Margin of AMS has grown nicely.
AMS has a Operating Margin (2.22%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AMS has declined.
AMS has a Gross Margin (27.31%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AMS has remained more or less at the same level.
Industry RankSector Rank
OM 2.22%
PM (TTM) 4.93%
GM 27.31%
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
AMS Yearly Profit, Operating, Gross MarginsAMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMS is destroying value.
Compared to 1 year ago, AMS has more shares outstanding
AMS has more shares outstanding than it did 5 years ago.
AMS has a worse debt/assets ratio than last year.
AMS Yearly Shares OutstandingAMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
AMS Yearly Total Debt VS Total AssetsAMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

AMS has an Altman-Z score of 1.07. This is a bad value and indicates that AMS is not financially healthy and even has some risk of bankruptcy.
AMS's Altman-Z score of 1.07 is on the low side compared to the rest of the industry. AMS is outperformed by 69.90% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that AMS is somewhat dependend on debt financing.
AMS's Debt to Equity ratio of 0.76 is in line compared to the rest of the industry. AMS outperforms 44.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACC0.11
WACC9.23%
AMS Yearly LT Debt VS Equity VS FCFAMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.87 indicates that AMS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.87, AMS is in the better half of the industry, outperforming 67.96% of the companies in the same industry.
A Quick Ratio of 1.87 indicates that AMS should not have too much problems paying its short term obligations.
AMS's Quick ratio of 1.87 is fine compared to the rest of the industry. AMS outperforms 69.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.87
AMS Yearly Current Assets VS Current LiabilitesAMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

AMS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -300.00%.
Measured over the past years, AMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.28% on average per year.
The Revenue has grown by 35.26% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 6.58% on average over the past years.
EPS 1Y (TTM)-300%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%-600%
Revenue 1Y (TTM)35.26%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%17.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y168.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMS Yearly Revenue VS EstimatesAMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
AMS Yearly EPS VS EstimatesAMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 0.2 -0.2 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

AMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 16.44, the valuation of AMS can be described as correct.
Based on the Price/Forward Earnings ratio, AMS is valued a bit cheaper than 69.90% of the companies in the same industry.
AMS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.28.
Industry RankSector Rank
PE N/A
Fwd PE 16.44
AMS Price Earnings VS Forward Price EarningsAMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

97.09% of the companies in the same industry are more expensive than AMS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.57
AMS Per share dataAMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

AMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AMS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN SHARED HOSPITAL SER

NYSEARCA:AMS (8/5/2025, 8:04:00 PM)

2.49

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-15 2025-05-15/dmh
Earnings (Next)08-13 2025-08-13
Inst Owners13.91%
Inst Owner Change-4.15%
Ins Owners34.16%
Ins Owner Change4.75%
Market Cap16.06M
Analysts80
Price Target4.95 (98.8%)
Short Float %1.64%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1039.6%
Min EPS beat(2)-2080.2%
Max EPS beat(2)0.99%
EPS beat(4)1
Avg EPS beat(4)-582.62%
Min EPS beat(4)-2080.2%
Max EPS beat(4)0.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)7.83%
Min Revenue beat(2)-0.96%
Max Revenue beat(2)16.61%
Revenue beat(4)2
Avg Revenue beat(4)5.32%
Min Revenue beat(4)-7.97%
Max Revenue beat(4)16.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-275%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.01%
Revenue NY rev (1m)-11.07%
Revenue NY rev (3m)-11.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.44
P/S 0.55
P/FCF N/A
P/OCF 3.54
P/B 0.65
P/tB 0.69
EV/EBITDA 3.57
EPS(TTM)-0.34
EYN/A
EPS(NY)0.15
Fwd EY6.08%
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)0.7
OCFY28.24%
SpS4.53
BVpS3.82
TBVpS3.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.28%
ROE 5.85%
ROCE 1.28%
ROIC 0.97%
ROICexc 1.24%
ROICexgc 1.28%
OM 2.22%
PM (TTM) 4.93%
GM 27.31%
FCFM N/A
ROA(3y)2.64%
ROA(5y)-1.57%
ROE(3y)5.84%
ROE(5y)-3.63%
ROIC(3y)4.67%
ROIC(5y)N/A
ROICexc(3y)6.77%
ROICexc(5y)N/A
ROICexgc(3y)7.11%
ROICexgc(5y)N/A
ROCE(3y)6.05%
ROCE(5y)N/A
ROICexcg growth 3Y-13.43%
ROICexcg growth 5Y-5.81%
ROICexc growth 3Y-13.18%
ROICexc growth 5Y-6.48%
OM growth 3Y-20.48%
OM growth 5Y-14.68%
PM growth 3Y92.72%
PM growth 5Y19.22%
GM growth 3Y-5.31%
GM growth 5Y-0.7%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA 2.71
Cap/Depr 171.25%
Cap/Sales 36.84%
Interest Coverage 0.43
Cash Conversion 65.37%
Profit Quality N/A
Current Ratio 1.87
Quick Ratio 1.87
Altman-Z 1.07
F-Score5
WACC9.23%
ROIC/WACC0.11
Cap/Depr(3y)86.06%
Cap/Depr(5y)59.68%
Cap/Sales(3y)19.8%
Cap/Sales(5y)14.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300%
EPS 3Y121.52%
EPS 5Y24.28%
EPS Q2Q%-600%
EPS Next Y168.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.26%
Revenue growth 3Y17.14%
Revenue growth 5Y6.58%
Sales Q2Q%17.18%
Revenue Next Year14.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-70.81%
EBIT growth 3Y-6.85%
EBIT growth 5Y-9.07%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-175.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.11%
OCF growth 3Y-70.14%
OCF growth 5Y-53.93%